Methotrexate pneumonitis in a patient with rheumatoid arthritis

Postgraduate Medical Journal

Volumn 73, Issue 863, 1997, Pages 603-604

  Clearkin, R ^a,b   Corns, P A ^a   Thomas, S H L ^b  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Adverse drug reaction; Methotrexate pneumonitis

Indexed keywords

METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; EMBRYOTOXICITY; ENTERITIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PNEUMONIA; RHEUMATOID ARTHRITIS;

EID: 0030848469     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.73.863.603     Document Type: Article

References (8)

1. Tariq S, Tariq SM. Methotrexate in rheumatoid arthritis: can current knowledge and experience justify its use as a first line disease modifying agent? Postgrad Med J 1993; 69: 775-80.
2. Weinblatt HE. Methotrexate in rheumatoid arthritis: toxicity issues. Br ℑ Rheumatol 1996; 35: 403-6.
3. Cottin V, Tebib J, Massonnet B, Souquet P-J, Bernard J-P. Pulmonary function in patients receiving long-term lowdose methotrexate. Chest 1996; 109: 933-8.
4. Barrera P, Laan RFJM, van Kiel PLCM, Dekhuijzen PNR, Boerbooms AMT, van de Putte LBA. Methotrexate-related pulmonary complications in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 434-9.
5. Searles G, McKendry RJR. Methotrexate pneumonias in rheumatoid arthritis: potential risk factors, four case reports and a review of the literature. ℑ Rheumatol 1987; 14: 1164-71.
6. Hilliquin P, Renoux M, Perrot S, Puéchal X, Menkès CJ. Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis. Br ℑ Rheumatol 1996; 35: 441-5.
7. Alarcón GS, Kremer JM, Macaluso M, et al. MTX-lung toxicity: a multi-centre, case-control study (abstract) Arthritis Rheum 1995; 38: S205.
8. Weber JCP, Essingman WK. Pulmonary alveolitis and NSAIDs-fact or fiction? Br J Rheumatol 1986; 25: 5-6.